Correlation of vascular endothelial growth factor with the severity of thalassemia intermedia

Blood Coagulation and Fibrinolysis

Volumn 19, Issue 7, 2008, Pages 611-614

  Shitrit, David ^a,b   Tamary, Hannah ^b,c   Koren, Ariel ^d,e   Levin, Carina ^d   Bargil Shitrit, Ariella ^f   Sulkes, Jaqueline ^a,b   Kramer, Mordechai R ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^d HAEMEK MEDICAL CENTER   (Israel)

^e TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^f SHAARE ZEDEK MEDICAL CENTER   (Israel)

Author keywords

Hepatomegaly; Splenomegaly; Thalassemia; Thrombosis

Indexed keywords

BIOLOGICAL MARKER; VASCULOTROPIN;

ADOLESCENT; ADULT; ARTICLE; BETA THALASSEMIA; BLOOD SAMPLING; CHILD; CLINICAL ARTICLE; CORRELATION ANALYSIS; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEPATOMEGALY; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SPLENECTOMY; SPLENOMEGALY; THALASSEMIA INTERMEDIA;

CHILD; HEPATOMEGALY; HUMANS; MALE; SEVERITY OF ILLNESS INDEX; SPLENOMEGALY; THALASSEMIA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 55049086670     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mbc.0000337599.87788.58     Document Type: Article

References (20)

1. Nathan DG, Orkin SH. Hematology of infancy and childhood. Vol. 1, 5th ed. Philadelphia, PA: WB Saunders; 1998. pp. 544-664.
2. Camaschella C, Cappellini MD. Thalassemia intermedia. Haematologica 1995; 80:58-68.
3. Aessopos A, Farmakis D, Kargiorga M, Voskaridou E, Loutradi A, Hatziliami A, et al. Cardiac involvement in thalassemia intermedia: a multicenter study. Blood 2001; 97:3411-3416.
4. Cappellini MD, Robbiolo L, Bottasso BM, Coppola R, Fiorelli G, Mannucci AP. Venous thromboembolism and hypercoagulability in splenectomized patients with thalassemia intermedia. Br J Haematol 2000; 111:467-473.
5. Eldor A, Rachmilewitz EA. The hypercoagulable state in thalassemia. Blood 2002; 99:36-43.
6. Cotran RS. New roles for the endothelium in inflammation and immunity. Am J Pathol 1987; 129:407-413.
7. Engelberg H. Endothelium in health and disease. Semin Thromb Haemost 1989; 15:178-183.
8. Fajardo LF. The complexity of endothelial cells: a review. Am J Clin Pathol 1989; 92:241-250.
9. Wall RT, Harker LA, Quadracci LJ, Striker GE. Factors influencing endothelial cell proliferation in vitro. J Cell Physiol 1978; 96:203-214.
10. Sonakul D, Fucharoen S. Pulmonary thromboembolism in thalassemic patients. Southeast Asian J Trop Med Public Health 1992; 23 (Suppl):25-28.
11. Ferrer MI. Cor pulmonale (pulmonary artery disease): present day status. Am Heart J 1975; 89:657-664.
12. Butthep P, Bunyaratvej A, Kitaguchi H, Funahara Y, Fucharoen S. Interaction between endothelial cells and thalassemic red cells in vitro. Southeast Asian J Trop Med Public Health 1992; 23 (Suppl 2):101-104.
13. Bunyaratvej A, Funahara Y, Butthep P, Kitaguchi H, Fucharoen S. Thalassemic serum impairs endothelial cell growth in vitro. Southeast Asian J Trop Med Public Health 1992; 23 (Suppl 2):105-109.
14. Butthep P, Khuhapinant A, Bunyaratveij A, Funahara Y, Kitaguchi H, Fucharoen S. Thalassemic serum inhibits endothelial cell mitosis in vitro. Southeast Asian J Trop Med Public Health 1997; 28 (Suppl 3):155-160.
15. Banjerdpongchai R, Wilairat P, Fucharoen S, Bunyaratvej A. Morphological alterations and apoptosis of endothelial cells induced by thalassemic serum in vitro. Southeast Asian J Trop Med Public Health 1997; 28 (Suppl 3): 149-154.
16. Butthep P, Bunyaratvej A, Funahara Y, Kitaguchi H, Fucharoen S, Sato S, et al. Possible evidence of endothelial cell activation and disturbance in thalassemia: an in vitro study. Southeast Asian J Trop Med Public Health 1997; 28 (Suppl 3):141-148a.
17. Butthep P, Rammavas S, Wisedpanichkij R, Jindadamrongwech S, Funchareon S, Bunyaratvej A. Increased circulation activated endothelial cells vascular endothelial growth factor, and tumor necrosis factor in thalassemia. Am J Hematol 2002; 70:100-106.
18. Dexter L. Thromboemboli as a cause of cor pulmonale. Bull NY Acad Med 1965; 41:481-488.
19. Minchenko A, Bauer T, Salceda S, Caro J. Hypoxic stimulation of vascular endothelial growth factor expression in vitro and in vivo. Lab Invest 1994; 71:374-379.
20. Dudst J, Pigorsch S, Hunsgen G, Hintner I, Lautenschlager C. Low hemoglobin is associated with increased serum levels of VEGF in cancer patients. Does anemia stimulate angiogenesis? Strahlenther Onkol 1999; 175:93-96.